This compound is primarily utilized in neuroscience research due to its role as a potent and selective inhibitor of glycine transporter 1 (GlyT1). By inhibiting GlyT1, it increases glycine levels in the synaptic cleft, which enhances NMDA receptor function. This mechanism makes it valuable for studying conditions related to NMDA receptor hypofunction, such as schizophrenia, cognitive disorders, and neurodegenerative diseases. Researchers also explore its potential in understanding synaptic plasticity and memory formation. However, its application is limited to preclinical studies due to its pharmacological profile and potential side effects.